Is Inovio Pharmaceuticals Inc (INO) Stock About to Get Hot Wednesday?

The market has been down on Inovio Pharmaceuticals Inc (INO) stock recently. INO gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.

Inovio Pharmaceuticals Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on INO!

See Full INO Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With INO Stock Today?

Inovio Pharmaceuticals Inc (INO) stock is down -4.95% while the S&P 500 has gained 0.49% as of 10:04 AM on Wednesday, Jan 24. INO has fallen -$0.03 from the previous closing price of $0.58 on volume of 537,571 shares. Over the past year the S&P 500 has risen 21.61% while INO has fallen -66.67%. INO lost -$0.64 per share in the over the last 12 months.

More About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies. Click Here to get the full Stock Report for Inovio Pharmaceuticals Inc stock.